| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.08 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.096 | 0.09 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.09 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.09 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.073 | 0.09 |